OTCMREMI
Market cap1mUSD
Dec 18, Last price
0.06USD
Name
Remedent Inc
Chart & Performance
Profile
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. It also provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. In addition, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice, which enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Further, it provides dental implant solutions and treatment concepts. The company sells its products to dental professionals in approximately 30 countries, including Asia, Europe, the Middle East, Canada, and the United States through its internal sales force and third party distributors. The company was founded in 1986 and is headquartered in Ghent, Belgium.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 986 14.17% | 864 -38.63% | 1,408 36.68% | |||||||
Cost of revenue | 383 | 358 | 375 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 603 | 506 | 1,032 | |||||||
NOPBT Margin | 61.15% | 58.53% | 73.34% | |||||||
Operating Taxes | 17 | 18 | 23 | |||||||
Tax Rate | 2.75% | 3.51% | 2.27% | |||||||
NOPAT | 586 | 488 | 1,009 | |||||||
Net income | (274) -81.64% | (1,495) 481.24% | (257) 57.68% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 15 | 22 | ||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | (4,488) | (4,731) | (6,014) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (131) | (53) | (169) | |||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | 717 | 748 | 493 | |||||||
Balance | ||||||||||
Cash | 43 | 105 | 174 | |||||||
Long term investments | 4,460 | 4,625 | 5,863 | |||||||
Excess cash | 4,454 | 4,688 | 5,966 | |||||||
Stockholders' equity | (21,626) | (21,340) | (19,825) | |||||||
Invested Capital | 24,090 | 24,075 | 24,075 | |||||||
ROIC | 2.44% | 2.03% | 4.19% | |||||||
ROCE | 24.47% | 18.49% | 24.29% | |||||||
EV | ||||||||||
Common stock shares outstanding | 19,996 | 19,996 | 19,996 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 623 | 531 | 1,061 | |||||||
EV/EBITDA | ||||||||||
Interest | 4 | 7 | ||||||||
Interest/NOPBT | 0.82% | 0.72% |